newsfilter
← Latest News
GlobeNewswire·

BREAKING: Capricor Therapeutics Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm to Learn More

BOSTON, July 27, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Capricor Therapeutics (NASDAQ:CAPR) for potential securities law violations. Investors who have lost money in their Capricor Therapeutics